Work

Veliparib (ABT-888), Bendamustine, and Rituximab (VBR) Is Well Tolerated and Efficacious in Patients with Lymphoma: Final Analysis of a Phase 1b Clinical Trial of VB and a Cohort Expansion of Vbr in Patients with B-Cell Lymphoma

Year: 2015

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v126.23.2691.2691

Authors: Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, Anas Younes, Maria Lia Palomba, Paul A Hamlin, Ariela Noy, Steven M Horwitz, Matthew J. Matasar, Alison J Moskowitz, Carol S Portlock, David J Straus, Alice Chen, Richard F Little, Fallon France, Juho Whang, Nishant Mishra, Christine Jarjies, John F Gerecitano

Institutions: Memorial Sloan Kettering Cancer Center, National Cancer Institute

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2577545844

FWCI:

Cites:

Cited by:

Related to: 10